Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 86

1.

Naltrexone implant treatment for buprenorphine dependence--Mauritian case series.

Jhugroo A, Ellayah D, Norman A, Hulse G.

J Psychopharmacol. 2014 Aug;28(8):800-3. doi: 10.1177/0269881114528592. Epub 2014 Apr 2.

PMID:
24695742
2.

A systematic review and meta-analysis of naltrexone implants for the treatment of opioid dependence.

Larney S, Gowing L, Mattick RP, Farrell M, Hall W, Degenhardt L.

Drug Alcohol Rev. 2014 Mar;33(2):115-28. doi: 10.1111/dar.12095. Epub 2013 Dec 3. Review.

PMID:
24299657
3.

DSM IV axis II traits can influence compliance to treatment with oral naltrexone: a preliminary study on 30 opiate dependent patients.

Streel E, Chenut C, Papageorgiou C, Verbanck P.

Addict Behav. 2014 Jan;39(1):321-4. doi: 10.1016/j.addbeh.2013.08.031. Epub 2013 Sep 8.

PMID:
24090623
5.
6.

Injectable and implantable sustained release naltrexone in the treatment of opioid addiction.

Kunøe N, Lobmaier P, Ngo H, Hulse G.

Br J Clin Pharmacol. 2014 Feb;77(2):264-71. doi: 10.1111/bcp.12011. Review.

8.

Randomized trial of long-acting sustained-release naltrexone implant vs oral naltrexone or placebo for preventing relapse to opioid dependence.

Krupitsky E, Zvartau E, Blokhina E, Verbitskaya E, Wahlgren V, Tsoy-Podosenin M, Bushara N, Burakov A, Masalov D, Romanova T, Tyurina A, Palatkin V, Slavina T, Pecoraro A, Woody GE.

Arch Gen Psychiatry. 2012 Sep;69(9):973-81. doi: 10.1001/archgenpsychiatry.2012.1a.

9.

Characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives as novel leads to development of mu opioid receptor selective antagonists.

Yuan Y, Li G, He H, Stevens DL, Kozak P, Scoggins KL, Mitra P, Gerk PM, Selley DE, Dewey WL, Zhang Y.

ACS Chem Neurosci. 2011 Jul 20;2(7):346-51. doi: 10.1021/cn2000348. Epub 2011 May 6.

10.

Naltrexone implant for the treatment of polydrug dependence: a randomized controlled trial.

Tiihonen J, Krupitsky E, Verbitskaya E, Blokhina E, Mamontova O, Föhr J, Tuomola P, Kuoppasalmi K, Kiviniemi V, Zwartau E.

Am J Psychiatry. 2012 May;169(5):531-6.

PMID:
22764364
11.

A 'miracle cure' misunderstood.

Brewer C.

Addiction. 2012 Aug;107(8):1528. doi: 10.1111/j.1360-0443.2012.03912.x. Epub 2012 May 17. No abstract available.

PMID:
22594709
12.

Examination of mortality rates in a retrospective cohort of patients treated with oral or implant naltrexone for problematic opiate use.

Kelty E, Hulse G.

Addiction. 2012 Oct;107(10):1817-24. doi: 10.1111/j.1360-0443.2012.03910.x. Epub 2012 May 17.

PMID:
22487087
13.

Injectable extended-release naltrexone for opioid dependence.

Woody GE, Metzger DS.

Lancet. 2011 Aug 20;378(9792):664-5; author reply 666. doi: 10.1016/S0140-6736(11)61330-5. No abstract available.

PMID:
21856476
14.

Pharmacological enhancement of naltrexone treatment for opioid dependence: a review.

Mannelli P, Peindl KS, Wu LT.

Subst Abuse Rehabil. 2011 Jun;2011(2):113-123.

15.

Naltrexone depot formulations for opioid and alcohol dependence: a systematic review.

Lobmaier PP, Kunøe N, Gossop M, Waal H.

CNS Neurosci Ther. 2011 Dec;17(6):629-36. doi: 10.1111/j.1755-5949.2010.00194.x. Review.

PMID:
21554565
16.

[The use of different forms of naltrexone in the treatment of opioid dependence].

Krupitskiĭ EM, Zvartau EE, Blokhina EA, Woody G.

Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(11 Pt 2):66-72. Russian.

PMID:
22611701
18.

Challenges to antagonist blockade during sustained-release naltrexone treatment.

Kunøe N, Lobmaier P, Vederhus JK, Hjerkinn B, Gossop M, Hegstad S, Kristensen Ø, Waal H.

Addiction. 2010 Sep;105(9):1633-9. doi: 10.1111/j.1360-0443.2010.03031.x.

PMID:
20707781
19.

Russian injected drug use soars in face of political inertia.

Holt E.

Lancet. 2010 Jul 3;376(9734):13-4. No abstract available.

PMID:
20626081
20.

Retention in naltrexone implant treatment for opioid dependence.

Kunøe N, Lobmaier P, Vederhus JK, Hjerkinn B, Hegstad S, Gossop M, Kristensen O, Waal H.

Drug Alcohol Depend. 2010 Sep 1;111(1-2):166-9. doi: 10.1016/j.drugalcdep.2010.03.021. Epub 2010 May 31.

PMID:
20570059
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk